• 1. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 2. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 3. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 4. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 5. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625

Introduction to (2-(methoxy-d3)-6-(trifluoromethyl)pyridin-4-yl)boronic Acid (CAS No. 2241875-96-5)

(2-(methoxy-d3)-6-(trifluoromethyl)pyridin-4-yl)boronic acid is a specialized organoboron compound that has garnered significant attention in the field of pharmaceutical and chemical research. This compound, identified by its CAS number 2241875-96-5, is a derivative of pyridine with unique structural and functional properties that make it valuable in various synthetic applications. The presence of a trifluoromethyl group and a deuterated methoxy group enhances its reactivity and stability, making it particularly useful in the development of fine chemicals and pharmaceutical intermediates.

The compound's structure consists of a pyridine ring substituted at the 2-position with a methoxy-d3 group and at the 6-position with a trifluoromethyl group. The boronic acid functionality at the 4-position of the pyridine ring allows for further derivatization through cross-coupling reactions, such as Suzuki-Miyaura coupling, which is widely employed in the synthesis of complex organic molecules. These reactions are pivotal in constructing biaryl structures, which are prevalent in many biologically active compounds.

In recent years, there has been a surge in research focused on the development of boronic acid derivatives due to their utility in pharmaceutical synthesis. The trifluoromethyl group is particularly noteworthy as it introduces electron-withdrawing properties, influencing the electronic characteristics of the molecule. This can be advantageous in modulating the reactivity and binding affinity of drug candidates. Additionally, the deuterated methoxy group (methoxy-d3) provides a means to study metabolic pathways and interactions through deuterium labeling techniques, which are increasingly employed in drug metabolism studies.

The application of this compound extends beyond academic research; it has found practical use in industrial settings where high-purity intermediates are required. The stability and predictability of (2-(methoxy-d3)-6-(trifluoromethyl)pyridin-4-yl)boronic acid under various reaction conditions make it a preferred choice for large-scale synthesis. Moreover, its compatibility with green chemistry principles, such as minimal waste generation and energy efficiency, aligns with the growing emphasis on sustainable chemical practices.

Recent advancements in computational chemistry have further highlighted the potential of this compound. Molecular modeling studies have demonstrated that the electronic distribution influenced by the trifluoromethyl and boronic acid groups can be leveraged to design molecules with enhanced pharmacological properties. These insights are being translated into experimental protocols, leading to more efficient synthetic routes and improved yields.

The role of boronic acids in drug discovery cannot be overstated. They serve as key intermediates in the synthesis of numerous therapeutic agents, including anticancer and anti-inflammatory drugs. The ability to introduce specific functional groups while maintaining structural integrity makes compounds like (2-(methoxy-d3)-6-(trifluoromethyl)pyridin-4-yl)boronic acid indispensable in medicinal chemistry. Current research is exploring novel derivatives to optimize their pharmacokinetic profiles and therapeutic efficacy.

In conclusion, (2-(methoxy-d3)-6-(trifluoromethyl)pyridin-4-yl)boronic acid (CAS No. 2241875-96-5) represents a significant advancement in organoboron chemistry. Its unique structural features and versatile reactivity make it a valuable tool for both academic researchers and industrial chemists. As our understanding of molecular interactions continues to evolve, compounds like this will undoubtedly play a crucial role in the development of next-generation pharmaceuticals.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)